Innovating Works
GLIOVACC: Augmenting and broadening T cell responses to glioblastoma therapeutic vaccine platform based on H... SVEUCILISTE U RIJECI MEDICINSKI FAKULTET tramitó un H2020: ERC-2018-PoC The development of an effective vaccine against human cancers is of tremendous importance. Glioblastoma multiforme (GBM) is the most maligna...
2018-11-15 - 2020-07-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.